Literature DB >> 23541930

Single-step grafting of aminooxy-peptides to hyaluronan: a simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.

Joshua Sestak1, Meagan Mullins, Laura Northrup, Sharadvi Thati, M Laird Forrest, Teruna J Siahaan, Cory Berkland.   

Abstract

The immune response to antigens is directed in part by the presence or absence of costimulatory signals. The ability to coincidently present both antigen and, for example, a peptide that inhibits or activates the costimulatory pathway, would be a valuable tool for tolerization or immunization, respectively. A simple reaction scheme utilizing oxime chemistry was identified as a means to efficiently conjugate different peptide species to hyaluronan. Peptides synthesized with an aminooxy N-terminus reacted directly to hyaluronan under slightly acidic aqueous conditions without the need for a catalyst. The resulting oxime bond was found to rapidly hydrolyze at pH2 releasing peptide, but was stable at higher pH values (5.5 and 7). Two different peptide species, a multiple sclerosis antigen (PLP) and an ICAM-1 ligand (LABL) known to block immune cell stimulation, were functionalized with the aminooxy end group. These peptides showed similar reactivity to hyaluronan and were conjugated in an equimolar ratio. The resulting hyaluronan with grafted PLP and LABL significantly inhibited disease in mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Aminooxy-peptides facilitate simple synthesis of multifunctional hyaluronan graft polymers, thus enabling novel approaches to antigen-specific immune modulation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541930      PMCID: PMC3672265          DOI: 10.1016/j.jconrel.2013.03.015

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  49 in total

1.  Biological activities of cytokine-neutralizing hyaluronic acid-antibody conjugates.

Authors:  Liang Tso Sun; Sidi A Bencherif; Thomas W Gilbert; Adam M Farkas; Michael T Lotze; Newell R Washburn
Journal:  Wound Repair Regen       Date:  2010-04-15       Impact factor: 3.617

2.  Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation.

Authors:  K Moriyama; T Ooya; N Yui
Journal:  J Control Release       Date:  1999-05-01       Impact factor: 9.776

3.  Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.

Authors:  E Galluzzo; N Albi; S Fiorucci; C Merigiola; L Ruggeri; A Tosti; C E Grossi; A Velardi
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

4.  Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan-lipid conjugates.

Authors:  Dipali Ruhela; Kareen Riviere; Francis C Szoka
Journal:  Bioconjug Chem       Date:  2006 Sep-Oct       Impact factor: 4.774

5.  Conjugation of oligosaccharides by reductive amination to amine modified chondroitin oligomer and gamma-cyclodextrin.

Authors:  Krista Weikkolainen; Olli Aitio; Maria Blomqvist; Jari Natunen; Jari Helin
Journal:  Glycoconj J       Date:  2007-02-01       Impact factor: 2.916

6.  Functionalization of reactive polymer multilayers with RGD and an antifouling motif: RGD density provides control over human corneal epithelial cell-substrate interactions.

Authors:  Elizabeth J Tocce; Adam H Broderick; Kaitlin C Murphy; Sara J Liliensiek; Christopher J Murphy; David M Lynn; Paul F Nealey
Journal:  J Biomed Mater Res A       Date:  2011-10-04       Impact factor: 4.396

7.  Well-defined polymers with activated ester and protected aldehyde side chains for bio-functionalization.

Authors:  Jungyeon Hwang; Ronald C Li; Heather D Maynard
Journal:  J Control Release       Date:  2007-04-21       Impact factor: 9.776

8.  GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

Authors:  F Helling; A Shang; M Calves; S Zhang; S Ren; R K Yu; H F Oettgen; P O Livingston
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

9.  Positively and negatively modulating cell adhesion to type I collagen via peptide grafting.

Authors:  Gary A Monteiro; Anthony V Fernandes; Harini G Sundararaghavan; David I Shreiber
Journal:  Tissue Eng Part A       Date:  2009-01-27       Impact factor: 3.845

10.  Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agent.

Authors:  Taryn R Bagby; Shuang Cai; Shaofeng Duan; Sharadvi Thati; Daniel J Aires; Laird Forrest
Journal:  Pharmaceutics       Date:  2012-05-23       Impact factor: 6.321

View more
  12 in total

1.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

2.  Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.

Authors:  Joshua O Sestak; Amir Fakhari; Ahmed H Badawi; Teruna J Siahaan; Cory Berkland
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

3.  Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.

Authors:  Christopher Kuehl; Sharadvi Thati; Bradley Sullivan; Joshua Sestak; Michael Thompson; Teruna Siahaan; Cory Berkland
Journal:  J Pharm Sci       Date:  2017-06-15       Impact factor: 3.534

4.  Autoantigen Tetramer Silences Autoreactive B Cell Populations.

Authors:  Matthew A Christopher; Stephanie N Johnson; J Daniel Griffin; Cory J Berkland
Journal:  Mol Pharm       Date:  2020-10-06       Impact factor: 4.939

5.  Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.

Authors:  Laura Northrup; Joshua O Sestak; Bradley P Sullivan; Sharadvi Thati; Brittany L Hartwell; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  AAPS J       Date:  2014-10-09       Impact factor: 4.009

6.  Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis.

Authors:  Sharadvi Thati; Christopher Kuehl; Brittany Hartwell; Joshua Sestak; Teruna Siahaan; M Laird Forrest; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-12-01       Impact factor: 3.534

Review 7.  Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.

Authors:  Mario E G Moral; Teruna J Siahaan
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

8.  Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro.

Authors:  Chuda Chittasupho; Joshua Sestak; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Mol Pharm       Date:  2013-12-04       Impact factor: 4.939

9.  Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Laura Northrup; Matthew A Christopher; J Daniel Griffin; Francisco Martinez-Becerra; Cory Berkland
Journal:  J Autoimmun       Date:  2018-07-13       Impact factor: 7.094

10.  Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes.

Authors:  Rebuma Firdessa-Fite; Stephanie N Johnson; Martin A Leon; Mohsen Khosravi-Maharlooei; Rocky L Baker; Joshua O Sestak; Cory Berkland; Remi J Creusot
Journal:  Diabetes       Date:  2021-01-19       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.